A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis
暂无分享,去创建一个
Virginia Pascual | Jinghua Gu | Sebastian Amigorena | Karolina Palucka | Nicole Baldwin | Alma-Martina Cepika | V. Pascual | J. Banchereau | K. Palucka | G. Obermoser | N. Baldwin | M. Punaro | R. Banchereau | Victoria Cantrell | E. Anguiano | J. Baisch | S. Amigorena | E. Segura | Jacques Banchereau | Marilynn Punaro | S. Zurawski | Romain Banchereau | Brandi Cantarel | Esperanza Anguiano | Gerlinde Obermoser | Jinghua Gu | Sandra Zurawski | Phuong Nguyen | Elodie Segura | Brandi Cantarel | A. Cepika | P. Nguyen | Marina Ohouo | Kristina Goller | Victoria Cantrell | Emily Ruchaud | Elizabeth Gatewood | Jeanine M Baisch | K. Goller | E. Gatewood | Emily Ruchaud | Marina Ohouo
[1] T. Lehman,et al. Systemic Arthritis in Children: A Review of Clinical Presentation and Treatment , 2011, International journal of inflammation.
[2] M. Colonna,et al. Aryl hydrocarbon receptor: Linking environment to immunity. , 2015, Seminars in immunology.
[3] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[4] V. Pascual,et al. Assessing the human immune system through blood transcriptomics , 2010, BMC Biology.
[5] E. Giannini,et al. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. , 2004, The Journal of rheumatology.
[6] R. Cron,et al. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment , 2012, Genes and Immunity.
[7] Y. Fujii‐Kuriyama,et al. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses , 2009, The Journal of experimental medicine.
[8] M. Geffard,et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway , 2014, Nature.
[9] M. Hedger,et al. Activin and related proteins in inflammation: not just interested bystanders. , 2009, Cytokine & growth factor reviews.
[10] A. Ivetic. Signals regulating L-selectin-dependent leucocyte adhesion and transmigration. , 2013, The international journal of biochemistry & cell biology.
[11] Bronwen L. Aken,et al. GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.
[12] Naděžda Brdičková,et al. CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs , 2006, Nature.
[13] C. Sandborg,et al. Randomized, Double‐Blind, Placebo‐Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis , 2014, Arthritis & rheumatology.
[14] Pedro Romero,et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. , 2011, Immunity.
[15] R. Goldbach-Mansky,et al. IL-1 blockade in autoinflammatory syndromes. , 2014, Annual review of medicine.
[16] F. Gonzalez,et al. Aryl hydrocarbon receptor influences nitric oxide and arginine production and alters M1/M2 macrophage polarization. , 2016, Life sciences.
[17] A. Rubartelli,et al. The secretion of IL-1β and options for release. , 2013, Seminars in immunology.
[18] Martin Vingron,et al. PASTAA: identifying transcription factors associated with sets of co-regulated genes , 2008, Bioinform..
[19] J. Cyster,et al. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. , 2012, Annual review of immunology.
[20] E. Schadt,et al. Unifying immunology with informatics and multiscale biology , 2014, Nature Immunology.
[21] V. Pascual,et al. RNA recognition by human TLR8 can lead to autoimmune inflammation , 2013, The Journal of experimental medicine.
[22] V. Pascual,et al. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade , 2005, The Journal of experimental medicine.
[23] E. Marcotte,et al. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses , 2012, Nature Reviews Genetics.
[24] V. Pascual,et al. A genomic approach to human autoimmune diseases. , 2010, Annual review of immunology.
[25] C. Coch,et al. A Human In Vitro Whole Blood Assay to Predict the Systemic Cytokine Response to Therapeutic Oligonucleotides Including siRNA , 2013, PloS one.
[26] Naděžda Brdičková,et al. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. , 2006, Nature.
[27] B. Stockinger,et al. The aryl hydrocarbon receptor: multitasking in the immune system. , 2014, Annual review of immunology.
[28] Simon Yu,et al. INTERFEROME v2.0: an updated database of annotated interferon-regulated genes , 2012, Nucleic Acids Res..
[29] Virginia Pascual,et al. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade , 2009, The Journal of Experimental Medicine.
[30] Z. Sułowska,et al. Spontaneous Apoptosis of Neutrophils in Whole Blood and its Relation to Apoptosis Gene Proteins , 2000, Scandinavian journal of immunology.
[31] T. Ideker,et al. A decade of systems biology. , 2010, Annual review of cell and developmental biology.
[32] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[33] Prahlad T. Ram,et al. Cancer Systems Biology: a peek into the future of patient care? , 2014, Nature Reviews Clinical Oncology.
[34] Vincent Rouilly,et al. Standardized Whole-Blood Transcriptional Profiling Enables the Deconvolution of Complex Induced Immune Responses. , 2016, Cell reports.
[35] C. Wouters,et al. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. , 2012, The New England journal of medicine.
[36] C. Wouters,et al. Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients , 2014, Arthritis & rheumatology.
[37] Vincent Rouilly,et al. Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli. , 2014, Immunity.
[38] Steve Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[39] N Baldwin,et al. A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4 , 2014, Nature Immunology.
[40] M. Kizaki,et al. Activin A regulates the production of mature interleukin-1beta and interleukin-1 receptor antagonist in human monocytic cells. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[41] Steven L Salzberg,et al. HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.
[42] A. Horne,et al. Macrophage activation syndrome in the era of biologic therapy , 2016, Nature Reviews Rheumatology.
[43] A. Begovich,et al. Alternative activation in systemic juvenile idiopathic arthritis monocytes. , 2012, Clinical immunology.
[44] N. Hacohen,et al. Aryl Hydrocarbon Receptor Controls Monocyte Differentiation into Dendritic Cells versus Macrophages. , 2017, Immunity.
[45] Paul Theodor Pyl,et al. HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[46] W. Huai,et al. Aryl hydrocarbon receptor negatively regulates NLRP3 inflammasome activity by inhibiting NLRP3 transcription , 2014, Nature Communications.
[47] Virginia Pascual,et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. , 2008, Immunity.
[48] Emily A. Stevens,et al. The Aryl Hydrocarbon Receptor Signaling Pathway Is Modified through Interactions with a Kelch Protein , 2006, Molecular Pharmacology.
[49] E. Wherry,et al. Integrating genomic signatures for immunologic discovery. , 2010, Immunity.
[50] Paul Landais,et al. Extended Report , 2022 .
[51] V. Pascual,et al. Identification of the Key Differential Transcriptional Responses of Human Whole Blood Following TLR2 or TLR4 Ligation In-Vitro , 2014, PloS one.
[52] Sean C. Bendall,et al. Single-cell systems-level analysis of human Toll-like receptor activation defines a chemokine signature in patients with systemic lupus erythematosus. , 2015, The Journal of allergy and clinical immunology.